What is SimpleTrials?
SimpleTrials operates as a specialized provider of Clinical Trial Management Systems (CTMS), offering a scalable, cloud-based architecture designed to streamline complex research workflows. The platform distinguishes itself by providing a compliant and validated environment that caters to the specific operational requirements of clinical trial sites and CROs. By maintaining an affordable, subscription-based model, the company effectively democratizes access to high-level trial management tools, ensuring that both small-scale studies and large-scale clinical programs can maintain rigorous data integrity and project oversight. Its market position is defined by a commitment to intuitive design and operational efficiency, which serves as a critical bridge for organizations seeking to modernize their research infrastructure without the prohibitive costs associated with legacy enterprise software.
How much funding has SimpleTrials raised?
SimpleTrials has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in SimpleTrials
PPP
Public-Private Partnership
What's next for SimpleTrials?
With the recent influx of capital, SimpleTrials is expected to prioritize the expansion of its feature set and the scaling of its customer success operations. The strategic focus will likely shift toward deepening integration capabilities with existing electronic data capture systems and enhancing real-time analytics for trial sponsors. As the clinical research landscape becomes increasingly digitized, the company is poised to capture additional market share by addressing the growing demand for agile, cost-effective, and regulatory-compliant management solutions. Future growth initiatives will likely involve strengthening its presence in international markets and further refining its subscription-based value proposition to maintain its competitive edge in the health-tech ecosystem.
See full SimpleTrials company page
